Evidence map›Paper›PMID 15326025›Full record

ArticleBiophysical journal2004

Molecular dynamics simulations of the 136 unique tetranucleotide sequences of DNA oligonucleotides. I. Research design and results on d(CpG) steps.

David L Beveridge, Gabriela Barreiro, K Suzie Byun, David A Case, Thomas E Cheatham, Surjit B Dixit, Emmanuel Giudice, Filip Lankas, Richard Lavery, John H Maddocks and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in Biophysical journal, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 94 papers.

0numbers the graph read from it
0cells of the map it votes in
94citing papers in PubMed
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

94 citing papers in PubMed, 270 citations in OpenAlex.

  1. hexABC seeking the physical code of DNA.Nature communications · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

34 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 9 institutions in 5 countries.

David L BeveridgeChemistry Department, Molecular Biology & Biochemistry Department, and Molecular Biophysics Program, Wesleyan University, Middletown, Connecticut 06459, USA. dbeveridge@weselyan.edu
Gabriela Barreiro
K Suzie Byun
David A Case
Thomas E Cheatham
Surjit B Dixit
Emmanuel Giudice
Filip Lankas
Richard Lavery
John H Maddocks
Roman Osman
Eleanore Seibert
Heinz Sklenar
Gautier Stoll
Kelly M Thayer
Péter Varnai
Matthew A Young
Wesleyan University · USInstitut de Biologie Physico-Chimique · FRÉcole Polytechnique Fédérale de Lausanne · CHIcahn School of Medicine at Mount Sinai · USCzech Academy of Sciences, J. Heyrovský Institute of Physical Chemistry · CZMax Delbrück Center · DEScripps Research Institute · USUniversity of California, Berkeley · USUniversity of Utah · US

Funding

TRAINING PROGRAM IN CANCER THERAPYT32CA078207 · NCI · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI James J Manfredi · 1999 to 2026
$11.6M
DYNAMICS OF DNA DAMAGE RECOGNITION BY REPAIR ENZYMESR01CA063317 · NCI · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI OSMAN, ROMAN · 1995 to 2004
$2.0M
DOCTORAL STUDIES IN MOLECULAR BIOPHYSICST32GM008271 · NIGMS · WESLEYAN UNIVERSITY · PI BEVERIDGE, DAVID LEWIS · 1988 to 2015
$1.8M
TRAINING PROGRAM IN CELLULAR AND MOLECULAR BIOLOGYT32GM008553 · NIGMS · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI MLODZIK, MAREK · 1995 to 2012
$1.6M
SOLVENT EFFECTS ON BIOMOLECULAR STRUCTURE AND PROCESSR01GM037909 · NIGMS · WESLEYAN UNIVERSITY · PI BEVERIDGE, DAVID LEWIS · 1986 to 2003
$1.2M
SOLVENT EFFECTS ON BIOMOLECULAR STRUCTURE AND PROCESSR37GM037909 · NIGMS · WESLEYAN UNIVERSITY · PI BEVERIDGE, DAVID LEWIS · 1989 to 1998
–
NCI NIH HHS CA 63317NCI NIH HHS CA78207NCI NIH HHS R01 CA063317NCI NIH HHS T32 CA078207NIGMS NIH HHS GM 08271NIGMS NIH HHS GM08553NIGMS NIH HHS GM37909NIGMS NIH HHS T32 GM008271NIGMS NIH HHS T32 GM008553Wellcome Trust
6 · The paper itself

Abstract

We describe herein a computationally intensive project aimed at carrying out molecular dynamics (MD) simulations including water and counterions on B-DNA oligomers containing all 136 unique tetranucleotide base sequences. This initiative was undertaken by an international collaborative effort involving nine research groups, the "Ascona B-DNA Consortium" (ABC). Calculations were carried out on the 136 cases imbedded in 39 DNA oligomers with repeating tetranucleotide sequences, capped on both ends by GC pairs and each having a total length of 15 nucleotide pairs. All MD simulations were carried out using a well-defined protocol, the AMBER suite of programs, and the parm94 force field. Phase I of the ABC project involves a total of approximately 0.6 mus of simulation for systems containing approximately 24,000 atoms. The resulting trajectories involve 600,000 coordinate sets and represent approximately 400 gigabytes of data. In this article, the research design, details of the simulation protocol, informatics issues, and the organization of the results into a web-accessible database are described. Preliminary results from 15-ns MD trajectories are presented for the d(CpG) step in its 10 unique sequence contexts, and issues of stability and convergence, the extent of quasiergodic problems, and the possibility of long-lived conformational substates are discussed.

Indexed as

Models, ChemicalModels, MolecularBase SequenceComputer SimulationDNAKineticsMolecular Sequence DataMotionNucleic Acid ConformationOligodeoxyribonucleotidesStructure-Activity RelationshipCPG-oligonucleotideDNAOligodeoxyribonucleotides

Identifiers

PMID15326025
PMCPMC1304892
OpenAlexW2150945052

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.